Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11164 | 937 | 47.8 | 94% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PAK4 | Author keyword | 40 | 79% | 3% | 26 |
2 | PAK1 | Author keyword | 40 | 50% | 6% | 57 |
3 | P21 ACTIVATED KINASE | Author keyword | 36 | 52% | 5% | 49 |
4 | PAK5 | Author keyword | 26 | 100% | 1% | 11 |
5 | PAK | Author keyword | 20 | 35% | 5% | 45 |
6 | GIT1 | Author keyword | 17 | 59% | 2% | 19 |
7 | P21 ACTIVATED KINASE 4 | Author keyword | 17 | 100% | 1% | 8 |
8 | PAK6 | Author keyword | 15 | 88% | 1% | 7 |
9 | BETA PIX | Author keyword | 12 | 56% | 2% | 15 |
10 | P21 ACTIVATED KINASE 1 | Author keyword | 12 | 59% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PAK4 | 40 | 79% | 3% | 26 | Search PAK4 | Search PAK4 |
2 | PAK1 | 40 | 50% | 6% | 57 | Search PAK1 | Search PAK1 |
3 | P21 ACTIVATED KINASE | 36 | 52% | 5% | 49 | Search P21+ACTIVATED+KINASE | Search P21+ACTIVATED+KINASE |
4 | PAK5 | 26 | 100% | 1% | 11 | Search PAK5 | Search PAK5 |
5 | PAK | 20 | 35% | 5% | 45 | Search PAK | Search PAK |
6 | GIT1 | 17 | 59% | 2% | 19 | Search GIT1 | Search GIT1 |
7 | P21 ACTIVATED KINASE 4 | 17 | 100% | 1% | 8 | Search P21+ACTIVATED+KINASE+4 | Search P21+ACTIVATED+KINASE+4 |
8 | PAK6 | 15 | 88% | 1% | 7 | Search PAK6 | Search PAK6 |
9 | BETA PIX | 12 | 56% | 2% | 15 | Search BETA+PIX | Search BETA+PIX |
10 | P21 ACTIVATED KINASE 1 | 12 | 59% | 1% | 13 | Search P21+ACTIVATED+KINASE+1 | Search P21+ACTIVATED+KINASE+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PAK1 | 84 | 70% | 7% | 70 |
2 | ALPHA PAK | 59 | 71% | 5% | 48 |
3 | P21 ACTIVATED KINASE | 47 | 30% | 14% | 132 |
4 | P21 ACTIVATED KINASES | 41 | 47% | 7% | 65 |
5 | PAK4 | 35 | 89% | 2% | 16 |
6 | GAMMA PAK | 34 | 70% | 3% | 28 |
7 | SERINE THREONINE KINASE PAK4 | 23 | 86% | 1% | 12 |
8 | GROUP II PAKS | 20 | 100% | 1% | 9 |
9 | PAK | 20 | 35% | 5% | 45 |
10 | INTERACTING EXCHANGE FACTOR | 18 | 83% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
PAK signalling during the development and progression of cancer | 2014 | 29 | 139 | 71% |
Biology of the p21-activated kinases | 2003 | 628 | 218 | 56% |
A tale of two Paks | 2008 | 136 | 85 | 84% |
Role of p-21-Activated Kinases in Cancer Progression | 2014 | 7 | 210 | 84% |
Pak protein kinases and their role in cancer | 2009 | 108 | 155 | 66% |
PAK signaling in oncogenesis | 2009 | 97 | 100 | 67% |
p21-activated kinases in cancer | 2006 | 267 | 145 | 49% |
P21-activated kinase 4-Not just one of the PAK | 2013 | 12 | 91 | 77% |
The emerging importance of group II PAKs | 2010 | 54 | 90 | 57% |
Targeting group II PAKs in cancer and metastasis | 2009 | 51 | 74 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOL SCI MC 2460 | 4 | 75% | 0.3% | 3 |
2 | CELL ADHES UNIT | 4 | 33% | 1.1% | 10 |
3 | BREAST CANC THEME | 2 | 67% | 0.2% | 2 |
4 | IMMUNOL IMM14 | 2 | 67% | 0.2% | 2 |
5 | MOL CELL BIOL GLAXO IMCB GRP | 2 | 67% | 0.2% | 2 |
6 | SECT VERTEBRATE DEV | 2 | 67% | 0.2% | 2 |
7 | GLAXO IMCB GRP | 2 | 27% | 0.6% | 6 |
8 | SGSK GRP | 1 | 38% | 0.3% | 3 |
9 | ERNESTO MARIO PHARM | 1 | 50% | 0.2% | 2 |
10 | FUNCT GENOM MED TOPON | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163927 | TIAM1//RHOB//RHOGDI2 |
2 | 0.0000138070 | STE20 LIKE KINASE//MAP4K4//STE20 |
3 | 0.0000091333 | MIG 6//ACK1//RALT |
4 | 0.0000069703 | VAV//VAV1//VAV3 |
5 | 0.0000063983 | PKN//PROTEIN KINASE C RELATED KINASE//PRK1 |
6 | 0.0000060753 | ADP RIBOSYLATION FACTOR//ARF6//CYTOHESIN |
7 | 0.0000059911 | NEDD9//HEF1//CRK |
8 | 0.0000056470 | PODOSOMES//INVADOPODIA//CORTACTIN |
9 | 0.0000052736 | IQGAP1//MELUSIN//IQGAP2 |
10 | 0.0000049936 | WISKOTT ALDRICH SYNDROME//X LINKED THROMBOCYTOPENIA//WISKOTT ALDRICH SYNDROME PROTEIN |